Drug Profile
PD 176078
Alternative Names: PD 0176078Latest Information Update: 23 Jul 2002
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics; Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 16 Sep 1999 New profile
- 16 Sep 1999 Preclinical development for Pain in USA (Unknown route)